j&j cfo joseph wolk on q2 earnings beat: very pleased with the performance overall
Published 1 month ago • 1.9K plays • Length 8:41Download video MP4
Download video MP3
Similar videos
-
6:07
j&j cfo joseph wolk on q2 earnings beat: we're in a very strong position for second half of 2023
-
4:16
j&j cfo joseph wolk on q4 earnings beat: near- and long-term looks very strong at the company
-
7:48
j&j cfo on q2 earnings, acquisitions and product portfolio
-
4:08
johnson & johnson cfo on q2 earnings beat
-
5:11
johnson & johnson cfo joseph wolk on q4 earnings beat
-
3:50
j&j cfo joseph wolk on q1 earnings
-
11:45
jnj stock is johnson and johnson stock a good buy
-
7:02
pepsico cfo hugh johnston on q2 earnings: we're driving margins through productivity
-
5:02
j&j ceo breaks down the plan to split into two public companies
-
4:53
johnson & johnson cfo on q2 earnings, raising guidance, covid-19 and more
-
3:53
j&j's q1 earnings miss was because of covid-19 vaccine: cfo joseph wolk
-
9:42
johnson & johnson cfo on q2 earnings, litigation, product pipeline
-
6:08
johnson & johnson cfo joseph wolk on q3 results: very well-positioned into 2024 and beyond
-
4:51
johnson & johnson cfo on second-quarter earnings beat
-
6:12
watch cnbc's full interview with johnson & johnson cfo joseph wolk
-
4:53
johnson & johnson shares rising as earnings report shows revenue beat
-
4:16
j&j cfo on q1 earnings beat, covid vaccine pause in u.s.
-
7:59
j&j cfo on q1 earnings, forecast and product pipeline
-
3:48
great scientific innovation continues to produce great financial results for our company: j&j cfo
-
4:37
johnson & johnson cfo joseph wolk on covid-19 study pause
-
4:13
johnson & johnson cfo joseph wolk on supply challenges of tylenol, motrin
-
7:58
johnson & johnson cfo talks q2 earnings, medtech business